![Stephen Wargacki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 1 M $ op 30-06-2026
Stephen Wargacki formerly worked at Aquestive Therapeutics, Inc., as Senior Vice President-Research & Development from 2023 to 2024.
Dr. Wargacki received his doctorate degree from the University of Tennessee and undergraduate degree from the University of the Cumberlands.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-03-2025 | 343.552 ( 0,27% ) | 1 M $ | 30-06-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
University of Tennessee
 University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Cumberlands
 University of the Cumberlands Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
